Neptune Technologies & Bioressources Inc(NEPT)
0.25
Change: 0 (0)
As of Tue 12/20/2022 12:20 PM% Of Value
Growth
Value Per Share
:
:
:
153.21
-41.67
0.3800 (as of 19/12/2022)
Fundamentals Data
| Open | 0.36 | Dividend | 61 |
| Close Price | 0.25 | DivYield | 0 % |
| High | 0.3603 | Growth | -11.2 M |
| Low | 0.2304 | Growth% | -41.67 |
| P/e | 36.198 | Volume | 1.0 M |
| P/b | -0.05 | Market Capital | 19.4 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 1.00 (as of 20/12/2022) | 50 Days Moving Average Percentage | -156.32 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2014 | Year2 / 2015 | Year3 / 2016 | Year4 / 2017 | Current Year / 2018 |
| Revenue | 19.4 M | 15.0 M | 22.6 M | 46.8 M | 27.6 M |
| Cap Spending | -16.5 M | -17.9 M | -1.1 M | -2.9 M | -1.2 M |
| Operating Expenses | 24.4 M | 31.5 M | 19.3 M | 6.5 M | 5.1 M |
| Operating Cash Flow | -21.9 M | -39.5 M | -14.7 M | 6.2 M | 1.1 M |
| Free Cash Flow | -34.7 M | -40.6 M | -12.5 M | 4.8 M | -8.8 M |
| Free Cash Flow Per Share | -0.571 | -0.546 | -0.166 | 0.062 | -0.113 |
| Total liabilities | 10.0 M | 14.5 M | 27.6 M | 24.7 M | 4.6 M |
| Total cash | 6.5 M | 4.2 M | 5.4 M | 15.8 M | 24.2 M |
| ROE% | -0.417 | -0.564 | -0.199 | 0.124 | |
| Outstanding Shares | 61.8 M | 75.3 M | 77.9 M | 77.9 M | 78.8 M |
| P/E | -7.362 | -4.025 | -11.393 | 98.178 | 36.198 |
| P/S | 8.397 | 7.965 | 5.452 | 1.845 | 12.229 |
| Revenue USD | 17.9 M | 12.1 M | 17.2 M | 35.9 M | 20.9 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|